Two TPX2-dependent switches control the activity of Aurora A

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Xu, Xue ^a   Wang, Xia ^a   Xiao, Zhengtao ^a   Li, Yan ^b,c   Wang, Yonghua ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AURORA A KINASE; MICROTUBULE ASSOCIATED PROTEIN; TPX2 PROTEIN; UNCLASSIFIED DRUG; AURORA KINASE; CELL CYCLE PROTEIN; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; TPX2 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; WILD TYPE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MUTATION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BINDING SITES; CELL CYCLE PROTEINS; ENZYME ACTIVATION; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR DYNAMICS SIMULATION; MUTATION; NUCLEAR PROTEINS; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 79951778220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016757     Document Type: Article

References (29)

1. Fu J, Bian M, Jiang Q, Zhang C, (2007) Roles of Aurora Kinases in Mitosis and Tumorigenesis. Mol Cancer Res 5: 1-10.
2. Marumoto T, Honda S, Hara T, Nitta M, Hirota T, et al. (2003) Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem 278: 51786-51795.
3. Vader G, Lens S, (2008) The Aurora kinase family in cell division and cancer. Biochim Biophys Acta BBA 1786: 60-72.
4. Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr, et al. (2008) Aurora Kinases as Anticancer Drug Targets. Clin Cancer Res 14: 1639-1648.
5. Zhou H, Kuang J, Zhong L, Kuo WL, Gray J, et al. (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193.
6. Giet R, Petretti C, Prigent C, (2005) Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol 15: 241-250.
7. Marumoto T, Zhang D, Saya H, (2005) Aurora-A-A guardian of poles. Nat Rev Cancer 5: 42-50.
8. Moyer ML, Gilbert SP, Johnson KA, (1998) Pathway of ATP hydrolysis by monomeric and dimeric kinesin. Biochemistry 37: 800-813.
9. Goodsell DS, Cassier P, (1996) Our molecular nature: The body's motors, machines and messages. Heidelberg SpringerLink Press.
10. Hirota T, Kunitoku N, Sasayama T, Marumoto T, Zhang D, et al. (2003) Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114: 585-598.
11. Satinover DL, Leach CA, Stukenberg PT, Brautigan DL, (2004) Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proc Natl Acad Sci USA 101: 8625-8630.
12. Pugacheva EN, Golemis EA, (2005) The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol 7: 937-946.
13. Hutterer A, Berdnik D, Wirtz-Peitz F, Zigman M, Schleiffer A, et al. (2006) Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev Cell 11: 147-157.
14. Bibby RA, Tang C, Faisal A, Drosopoulos K, Lubbe S, et al. (2009) A cancer-associated Aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2. J Biol Chem 284: 33177-33184.
15. Bayliss R, Sardon T, Vernos I, Conti E, (2003) Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol Cell 12: 851-862.
16. Zhao B, Smallwood A, Yang J, Koretke K, Nurse K, et al. (2008) Modulation of kinase-inhibitor interactions by auxiliary protein binding: Crystallography studies on Aurora A interactions with VX-680 and with TPX2. Protein Sci 17: 1791-1797.
17. Agnese V, Bazan V, Fiorentino FP, Fanale D, Badalamenti G, et al. (2007) The role of Aurora-A inhibitors in cancer therapy. Ann Oncol 18: 47-52.
18. Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, et al. (2002) Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure 10: 1659-1667.
19. Groen AC, Needleman D, Brangwynne C, Gradinaru C, Fowler B, et al. (2008) A novel small-molecule inhibitor reveals a possible role of kinesin-5 in anastral spindle-pole assembly. J Cell Sci 121: 2293-2300.
20. Lu B, Wong CF, McCammon JA, (2005) Release of ADP from the catalytic subunit of protein kinase A: A molecular dynamics simulation study. Protein Sci 14: 159-168.
21. Eyers PA, Maller JL, (2003) Regulation of Xenopus Aurora A activation by TPX2. J Bio Chem 279: 9008-9015.
22. Wang J, Cieplak P, Kollman PA, (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules. J Comput Chem 21: 1049-1074.
23. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, et al. (2008) San Francisco, CA AMBER 10, University of California.
24. Meagher KL, Redman LT, Carlson HA, (2003) Development of polyphosphate parameters for use with the AMBER force field. J Comput Chem 24: 1016-1025.
25. Homeyer N, Horn AHC, Lanig H, Sticht H, (2006) AMBER force field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine and phosphohistidine. J Mol Model 12: 281-289.
26. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
27. Ryckaert JP, Ciccotti G, Berendsen HJC, (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23: 327-341.
28. Wu X, Brooks BR, (2003) Self-guided Langevin dynamics simulation method. Chem Phys Lett 381: 512-518.
29. Darden T, York D, Pederson L, (1993) Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. J Chem Phys 98: 10089-10092.